GB9103098D0 - Dermatological treatment - Google Patents

Dermatological treatment

Info

Publication number
GB9103098D0
GB9103098D0 GB919103098A GB9103098A GB9103098D0 GB 9103098 D0 GB9103098 D0 GB 9103098D0 GB 919103098 A GB919103098 A GB 919103098A GB 9103098 A GB9103098 A GB 9103098A GB 9103098 D0 GB9103098 D0 GB 9103098D0
Authority
GB
United Kingdom
Prior art keywords
dermatological treatment
dermatological
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB919103098A
Other versions
GB2251380B (en
GB2251380A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHUKLA RAM C
Original Assignee
SHUKLA RAM C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHUKLA RAM C filed Critical SHUKLA RAM C
Publication of GB9103098D0 publication Critical patent/GB9103098D0/en
Publication of GB2251380A publication Critical patent/GB2251380A/en
Application granted granted Critical
Publication of GB2251380B publication Critical patent/GB2251380B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB9103098A 1991-01-01 1991-02-14 Use of idoxuridine or acyclovir in the treatment of vitiligo Expired - Fee Related GB2251380B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1BO1991 1991-01-01

Publications (3)

Publication Number Publication Date
GB9103098D0 true GB9103098D0 (en) 1991-04-03
GB2251380A GB2251380A (en) 1992-07-08
GB2251380B GB2251380B (en) 1994-07-13

Family

ID=11076696

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9103098A Expired - Fee Related GB2251380B (en) 1991-01-01 1991-02-14 Use of idoxuridine or acyclovir in the treatment of vitiligo

Country Status (1)

Country Link
GB (1) GB2251380B (en)

Also Published As

Publication number Publication date
GB2251380B (en) 1994-07-13
GB2251380A (en) 1992-07-08

Similar Documents

Publication Publication Date Title
GB9115276D0 (en) Skin treatment system
GB9127150D0 (en) Novel treatment
PH25291A (en) Acne treatment
GB2257632B (en) Skin treatment device
GB2259251B (en) Massager
GB9203039D0 (en) Treatment
GB9222260D0 (en) Skin treatment
GB9217124D0 (en) Medical treatment
HU9200644D0 (en) Medical preparatives
GB9103098D0 (en) Dermatological treatment
GB9218773D0 (en) Skin treatment
GB9104175D0 (en) New treatment
GB9122334D0 (en) Medical treatment
GB9105560D0 (en) Novel treatment i
GB9103429D0 (en) Novel treatment
GB9115928D0 (en) Novel treatment
GB9113337D0 (en) Novel treatment
GB9112720D0 (en) Novel treatment
GB9114074D0 (en) Novel treatment
GB9111187D0 (en) Novel treatment
GB9111188D0 (en) Novel treatment
GB9112236D0 (en) Novel treatment
GB9112564D0 (en) Novel treatment
KR0111324Y1 (en) Massager
GB9204062D0 (en) Medical treatment

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20010214